pyridoxal has been researched along with Bone Loss, Osteoclastic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cathepsin L and/or K participate in bone resorption based on bone type-1 collagen degradation and the L-type protease inhibitors suppressed the bone resorption." | 1.30 | Study of the functional share of lysosomal cathepsins by the development of specific inhibitors. ( Asao, T; Kakegawa, T; Katunuma, N; Matsui, A; Murata, E; Ohba, Y, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katunuma, N | 2 |
| Matsui, A | 2 |
| Kakegawa, T | 1 |
| Murata, E | 2 |
| Asao, T | 2 |
| Ohba, Y | 2 |
| Inubushi, T | 1 |
| Kakegawa, H | 1 |
| Turk, D | 1 |
| Turk, V | 1 |
| Tada, Y | 1 |
2 other studies available for pyridoxal and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Study of the functional share of lysosomal cathepsins by the development of specific inhibitors.
Topics: Animals; Apoptosis; Bone Resorption; Caspase 3; Caspases; Catalytic Domain; Cathepsin L; Cathepsins; | 1999 |
Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.
Topics: Animals; Bone Resorption; Cathepsin B; Cathepsin K; Cathepsins; Cysteine Proteinase Inhibitors; Drug | 2000 |